Healthcare Industry News: Cytogen
News Release - August 25, 2008
Ikaria(R) Strengthens Commercial Operations and Human Resources LeadershipAppoints Stephen Ross Senior Vice President of Commercial Operations and James Briggs Senior Vice President of Human Resources
CLINTON, N.J., Aug. 25 (HSMN NewsFeed) -- Ikaria Holdings, Inc., a fully integrated critical care biotherapeutics company, announced today the addition of two key executives. Stephen A. Ross was appointed Senior Vice President of Commercial Operations and James Briggs was named Senior Vice President for Human Relations.
Daniel Tasse, President & CEO of Ikaria, remarked, "Steve and James add significant skills and experience to Ikaria as we continue to build our organization to achieve the leadership position in Critical Care. Steve infuses Ikaria with extensive experience in driving the marketing and sales of pharmaceutical products, while James brings with him a strong track record in creating operational efficiencies and driving employee development. We are confident that both will provide vital contributions to Ikaria as we advance our development pipeline and work to increase commercial opportunities for INOmax®. We are pleased to welcome Steve and James to the Ikaria team and look forward to working with them as we expand our organization to meet the needs of our growing business."
Mr. Ross previously served as Senior Vice President, Sales and Marketing at Cytogen, a specialty pharmaceutical company. At Cytogen, he was responsible for sales and marketing of Cytogen's four-product oncology portfolio. Prior to Cytogen, he spent fifteen years at GlaxoSmithKline where he held several positions, including Vice President, Specialist Business Units, GSK UK and General Manager of GSK Ireland. During his tenure at GSK, he managed sales and marketing for hospital and specialty products. Mr. Ross holds an MBA from The Wharton School, University of Pennsylvania and a BA in economics from Brigham Young University.
Mr. Briggs was previously Director, Human Resources of Avaya Global Services, a global IP Telephony Products and Services Company, where he led a human resources team that served more than 5,000 employees globally. Prior to joining Avaya, he served as Vice President, Human Resources at GE's Access Distribution, a global IT distributor with more than 600 employees. Before GE, he held human resources positions at Unilever and The Pepsi Bottling Company. Mr. Briggs holds an MA in industrial relations and a BA in communications, both from the University of Illinois.
About Ikaria Holdings, Inc.
Ikaria Holdings, Inc. is a fully integrated biotherapeutics company focused on the development and commercialization of innovative pharmaceutical and biological products and drug/device combinations for the critically ill in the hospital and ICU setting. The company's product, INOmax® (nitric oxide) for inhalation, is an FDA-approved drug for the treatment of hypoxic respiratory failure in term and near-term newborns. The drug also is approved by regulatory authorities and used in Canada, Europe, Australia and Latin America. In addition to the ongoing clinical development as well as the marketing and selling of its INOmax product, Ikaria is engaged in a number of Phase 2 trials with Covox® (carbon monoxide) for inhalation and Phase 1 trials with hydrogen sulfide (H2S) for various critical care indications. Ikaria has a staff of approximately 400 people and is headquartered in Clinton, NJ, with research facilities in Seattle, WA and Madison, WI and manufacturing in Port Allen, LA. For more information on Ikaria, please visit www.ikaria.com.
Source: Ikaria Holdings
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.